Read by QxMD icon Read

anticoagulants news

Li-Wei Lo, Tze-Fan Chao, Shih-Ann Chen
No abstract text is available yet for this article.
August 2016: Journal of Cardiovascular Electrophysiology
Françoise Boehlen, Marc Blondon, Pierre Fontana
This update describes contemporary studies of clinical relevance in angiology and hemostasis. We discuss newer developments for the treatment of haemophilia, with a focus on drugs with longer-half lives. Direct anticoagulants (DOAC: rivaroxaban, apixaban, edoxaban and dabigatran) and their approved prescription in Switzerland are summarized, with a description of antidotes that will be available in the near future. We will present new data on the utility of cancer screening at the diagnosis of idiopathic venous thromboembolism (VTE) and on the evaluation of DOAC in patients with cancer-related VTE...
January 13, 2016: Revue Médicale Suisse
E Laffitte
This article focuses on current trends in various autoimmune diseases of interest for the dermatologist. In the antiphospholipid syndrome, many news: better characterization of the severe disease, involvement of the mTOR pathway in the vasculopathy-induced renal disease, and diversification of the therapeutic approaches: use of mTOR inhibitors and several biologics, new various antiplatelet and anticoagulants. In dermatomyositis, new autoantibodies are better characterized with a good correlation with clinical disease; the results of a large study on genetic predisposition to the disease are available...
December 2014: Annales de Dermatologie et de Vénéréologie
J I Cuende, C Lahoz, P Armario, J García-Alegría, J Ena, G García de Casasola, J M Mostaza
During 2013 and the first months of 2014, numerous studies have been published in the cardiovascular field. New guidelines have appeared for managing arterial hypertension and reducing cardiovascular risk by lowering cholesterol levels. New data have emerged on the considerable lipid-lowering efficacy of monoclonal antibodies against PCSK-9, in contrast, however, to the clinical trials directed towards raising HDL-cholesterol with nicotinic acid, which have not shown a reduction in the rate of cardiovascular complications...
January 2015: Revista Clínica Española
Dronacharya Lamichhane
Stroke is becoming a major cause of morbidity and mortality in the developing world while the trend is actually downward in the developed nations. This is mostly because of the better recognition, treatment options and secondary prevention in addition to changes in lifestyles. There have been significant developments in the secondary prevention of ischaemic stroke in the last decade alone. Newer medications like direct thrombin inhibitors and factor Xa inhibitors have come into common practice. These medications are either equally effective or even better than age-old warfarin...
July 2014: JPMA. the Journal of the Pakistan Medical Association
Marianna Spatola, Andrea O Rossetti, Patrick Michel, Thierry Kuntzer, David Benninger, Bernard Nater, Jean-François Démonet, Myriam Schluep, Renaud A Du Pasquier, François Vingerhoets
In 2013, perampanel is approved as an add-on treatment for generalised and focal seizures in pharmaco-resistant epilepsy. New anticoagulants are superior to antivitamin K in stroke secondary prevention in case of atrial fibrillation. DBS remains a valid therapeutic option for advanced Parkinson's disease. Intranasal ketamine seems to reduce the intensity of severe migraine aura. High concentrations of topic capsaicin improve post-herpetic neuralgia. In Alzheimer's disease, statins might deteriorate cognitive functions...
January 15, 2014: Revue Médicale Suisse
Kartik Sunagar, Eivind A B Undheim, Holger Scheib, Eric C K Gren, Chip Cochran, Carl E Person, Ivan Koludarov, Wayne Kelln, William K Hayes, Glenn F King, Agosthino Antunes, Bryan Grieg Fry
UNLABELLED: Due to the extreme variation of venom, which consequently results in drastically variable degrees of neutralization by CroFab antivenom, the management and treatment of envenoming by Crotalus oreganus helleri (the Southern Pacific Rattlesnake), one of the most medically significant snake species in all of North America, has been a clinician's nightmare. This snake has also been the subject of sensational news stories regarding supposed rapid (within the last few decades) evolution of its venom...
March 17, 2014: Journal of Proteomics
Roberto Ervo
The technique of single needle dialysis (SN) was invented in the 1960s and enjoyed great success during the 1970s and '80s in northern Europe, particularly in Belgium. In recent years, the double needle mode has awakened new interest in this technique, as it may represent a good alternative to the use of a central venous catheter at the beginning of dialysis, while waiting for the growth of the arteriovenous fistula. For today's dialysis patients, mostly elderly with ever greater numbers of co-morbid conditions, in particular vascular disease, treatments have become ever more flexible and individually tailored...
May 2013: Giornale Italiano di Nefrologia: Organo Ufficiale Della Società Italiana di Nefrologia
José Carlos del Castillo Rodríguez, Ignacio Fernández Lozano
Atrial fibrillation (AF), is the most prevalent sustained arrhythmia in general population, affecting up to 10% in patients of advanced age. AF doubles overall mortality and increases up to 5-6 times the risk of stroke, which have the characteristic of being particularly harmful. The basis of treatment on AF are the rhythm or rate control and the prevention of thromboembolism. For the latter purpose the treatments that have been most effective are oral anticoagulants. For decades and until just a few years ago, the only oral drugs available for this purpose have been the anti-vitamin K, mainly represented in our country by acenocoumarol and lesser extent by warfarin...
April 2013: Atencion Primaria
J I Arcelus, F García-Bragado, D Jiménez, F S Lozano Sánchez, R Lecumberri, P Román Sánchez et al.
This paper brings together the latest developments that have occurred in different aspects of venous thromboembolism (VTE): VTE prophylaxis in high-risk orthopedic surgery and acutely ill hospitalized medical patients; therapeutic advances in pulmonary embolism and superficial vein thrombosis and VTE future prospects. It summarizes the reviews that five speakers made in-depth for the Second Day in New Anticoagulant Treatment, held in Madrid on November 18, 2011, organized by the Foundation for the Study of Thromboembolic Disease in Spain and endorsed by the Spanish Society of Internal Medicine, Spanish Society of Pneumology and Thoracic Surgery, Spanish Society of Cardiology, Spanish Society of Thrombosis and Haemostasis and the Spanish Society of Angiology and Vascular Surgery...
September 2012: Revista Clínica Española
(no author information available yet)
No abstract text is available yet for this article.
November 2011: Cardiovascular Journal of Africa
Céline Chauleur, Jean-Christophe Gris, Pierre Seffert, Patrick Mismetti
OBJECTIVES: State of the art of antithrombotics and their use recommendations during pregnancy. METHODS: A review RESULTS: Aspirin and heparins remain the safest molecules during pregnancy, and oral anticoagulants are still used for mechanical valves. Heparinoids are the methods of choice in case of heparin-induced thrombopenia but other molecules could find their place: fondaparinux at first and possibly the direct thrombin inhibitors. Thrombolysis may be used in case of life-threatening incident...
September 2011: Thérapie
X Rabasseda
As jazz and indeed most music has rhythm at its very core, so does life with the heart steadily pumping blood to the body. But as in jazz rhythm, irregular rhythm is paired with changes in pitch and velocity making melody and harmony, so it is to a large extent in heart disease, with irregular rhythm, irregular pumping effectiveness, arterial stiffness and so many diverse alterations completely changing the melody of life. Pairing music with the heart makes New Orleans a very reasonable place for the American College of Cardiology's scientific session to be held...
May 2011: Drugs of Today
(no author information available yet)
No abstract text is available yet for this article.
April 2011: Johns Hopkins Medical Letter Health After 50
Mihai Bîscă
No abstract text is available yet for this article.
2010: Oftalmologia
João Morais
Antithrombotic therapy is the cornerstone of management of patients with acute coronary syndromes. Its role has become increasingly important with the widespread use of percutaneous revascularization, particularly after stent implantation. In this context, use of dual antiplatelet therapy is mandatory, combining aspirin with thienopyridines, mostly clopidogrel. As well as antiplatelets, anticoagulants are also required in patients with acute myocardial infarction up to the time of percutaneous intervention and stent implantation...
May 2010: Portuguese Journal of Cardiology: An Official Journal of the Portuguese Society of Cardiology
Luis Alberto Ruiz Iturriaga, Adolfo Baloira
A significant number of studies on pulmonary circulation diseases have been published in 2009 that are likely to have a notable clinical impact. Anticoagulant treatment is on the verge of a significant change with the arrival of new oral drugs that have an inhibitory effect over factor X (rivaroxaban, apixaban) or thrombin (dabigatran). New studies have shown an efficacy comparable to enoxaparin in the prevention of thromboembolic disease and in some cases a lower risk of haemorrhage. Also interesting is a study on the incidence of pulmonary thromboembolism in patients with chronic obstructive pulmonary disease, a little known aspect...
March 2010: Archivos de Bronconeumología
C Francès
Brief virologic news included the discovery of the virophage, a unique parasite of the giant mimivirus and the association of HHV-8 infection with a peculiar form of African diabetes. Secondly, this news focused on risk factors for arterial or venous thrombosis and therapy for auto-immune disorders. Only oral estrogen therapy increases the risk of venous thromboembolism in postmenopausal women. Despite significant homocysteine lowering, vitamin supplementation with folic acid, vitamins B6 and B12 did not reduce total cardiovascular events among high-risk patients...
December 2008: Annales de Dermatologie et de Vénéréologie
P Berbis
This selection reviews several topics in the news: - in internal medicine, the cardiovascular and pulmonary risk factors in progressive systemic sclerosis (circulating lupus anticoagulant, smoking, NT-pro BNP marker); the relations between lupus erythematous and polymorphic light eruption, or Jessner-Kanof syndrome; the diagnostic score of autoinflammatory syndromes; and the dysmetabolism syndrome of psoriasis; - in infectious diseases, the return of epidemic typhus; the emergence of TIBOLA rickettsiosis; the development of methicillin-resistant Staphylococcus aureus strains in both the nosocomial and community settings; and finally news on herpes group viral infections...
December 2008: Annales de Dermatologie et de Vénéréologie
Piotr Kułakowski
No abstract text is available yet for this article.
September 2008: Kardiologia Polska
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"